DARA BioSciences has launched a liquid version of tamoxifen under the brand name Soltamox in the US
Tamoxifen Citrate is the most common drug prescribed to treat breast cancer.
Soltamox is expected to offer treatment option for patients who need tamoxifen and also solve difficulties of swallowing tamoxifen in solid form, according to the company.
DARA BioSciences,a specialty pharmaceutical company, focuses on oncology and oncology supportive care products.
Source:
http://drugdiscovery.pharmaceutical-business-review.com/news/dara-biosciences-introduces-tamoxifen-citrate-in-liquid-form-241012
